pharma

The first-quarter results of Swiss behemoth Kuehne + Nagel today highlighted one critical aspect for all the major asset-light logistics companies, which can be summed up by capital deployment risk – where to allocate the funds, how, when and why, based on expected returns, which can often be great on paper, but less so in reality.

In this respect, K+N has only one big option to grow inorganically, in my view, also given the emphasis that the company, in its investor ...

Daily News from £12 / mo  ·  includes Daily News

Comment on this article


You must be logged in to post a comment.